Try our Advanced Search for more refined results
March 18, 2011
Track this case
District Of Columbia
Other Statutory Actions
James E. Boasberg
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A federal judge in Washington on Monday tossed Mylan Pharmaceuticals Inc.'s suit to compel the U.S. Food and Drug Administration to weigh in on Ranbaxy Laboratories Ltd.'s exclusivity provision for marketing a generic version of Lipitor.
Already a subscriber? Click here to login